Yilin Du
- kawaokashinpei3
- 6 days ago
- 2 min read
Selected journal : Cell Metabolism
Brown fat protects against hepatic oxidative stress by remodeling the circulating metabolome
What is the main question of the paper?
This study investigates the molecular mechanisms by which brown adipose tissue (BAT) communicates with the liver through circulating metabolites, with a particular fo
cus on identifying BAT-derived signals that protect against hepatic oxidative stress.
How did the anthor address the question?
■Step1
The authors performed serum metabolomics and lipidomics in BAT-ablated and control mice under room temperature, cold exposure, and thermoneutral conditions. This “circulation-first” approach showed that BAT contributes to the clearance of circulating BCAAs and triglycerides and identified candidate metabolites that may be released from BAT.
■Step2
By integrating mouse serum data with tissue profiling, BAT extracellular fluid, BAT explant and brown-adipocyte conditioned media, and a human cohort with PET/CT-measured BAT activity, they identified 3-hydroxystearic acid, or 3-OHSA, as a metabolite enriched in and released by activated BAT. Cold-induced increases in circulating 3-OHSA were associated with higher BAT activity in both mice and humans.
■Step3
Using isolated liver mitochondria, the authors showed that 3-OHSA lowers mitochondrial membrane potential and reduces mitochondrial H2O2 production. In obese mice, 3-OHSA administration reduced hepatic lipid and protein oxidation without affecting body weight. Pharmacological inhibition experiments further suggested that its mitochondrial effect is mediated, at least partly, through adenine nucleotide translocase, particularly ANT2.
What is the strength of the paper?
The major strength of this paper is its comprehensive, cross-species experimental design, which connects unbiased discovery with mechanistic and functional validation. Rather than examining only metabolites secreted by cultured adipocytes, the authors used a “circulation-first” strategy combining serum metabolomics and lipidomics in BAT-ablated mice, multi-tissue source mapping, BAT explants and brown-adipocyte conditioned media, and a human cohort with BAT activity measured by FDG-PET/CT. This convergence of independent datasets allowed them to identify 3-hydroxystearic acid (3-OHSA) as a cold-inducible BAT-derived circulating metabolite with substantially stronger evidence than would be provided by a single model. Importantly, they then moved beyond association by demonstrating that physiologically relevant concentrations of 3-OHSA reduce hepatic mitochondrial membrane potential and ROS production, alleviate liver lipid and protein oxidation in vivo, and act at least partly through ANT2. Thus, the study provides a coherent chain of evidence from metabolite discovery, tissue origin and human relevance to molecular mechanism and physiological function.
Comment
I found the circulation-first approach very instructive. By using BAT ablation as a systemic perturbation and then profiling the circulating metabolome, the authors provide a useful framework for discovering how the loss or alteration of a key metabolic organ can reshape inter-organ communication.
Comment by Tomoaki Shirakawa
